Partnerships
One-Health Anti Microbial Resistance (OH AMR)
Partnership website: https://ohamr.eu/
The partnership aims to contribute to reducing the threat of antimicrobial resistance (AMR) by coordinating and aligning AMR activities and funding. Launched in June 2025,
The OH AMR partnership aims to coordinate and align activities and funding between countries as well as with the Commission. It will also facilitate national coherence between different services and ministries with responsibility for the various aspects of antimicrobial resistance (AMR) (e.g. human health, agriculture, environment, industry, finances).
The main goal is to contribute to achieving the objectives of the European One Health Action Plan against AMR and the WHO Global Action Plan on AMR, by reducing the threat of AMR.
Expected impact
- Novel solutions to prevent and treat infectious diseases affected by AMR, improved diagnosis and control of the spread of resistant microorganisms, testing and validation of such solutions and facilitating their uptake or implementation.
- Decreased burden of infectious diseases, notably due to AMR pathogens and progress towards Sustainable Development Goal No. 3 ‘Ensure healthy lives and promote well-being for all at all ages’.
- Closed knowledge gaps on AMR, support provided to regulatory science and inform policymaking.
Calls under the OH AMR Partnership
- The 2027 EUP OHAMR joint transnational call had been pre-announced in October 2026: Pre-announcment: Call to advance research on AMR transmission - EUP OHAMR (Flanders does not partcipate)
- The 2026 EUP OHAMR joint transnational call "Treatments and adherence to treatment protocols", involved 37 funding organisations from 28 different countries with an estimated total call budget of over 31 million Euro. Joint transnational call 2026 - EUP OHAMR
Timeline & key documents
- More information in the Draft outline of partnership proposal (February 2022)
- The CSA Design OH AMR was launched in May 2022 and is leading the development of the One Health AMR Partnership, in collaboration with the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR).
- A first draft of the European Partnership OH AMR Strategic Research and Innovation Agenda was published in May 2023. The final text of the SRIA has been published in August 2024.
- Start of activities in June 2025: Welcome to EUP OHAMR! - EUP OHAMR , kick-off event in September 2025: Successful kick-off in Brussels for the EUP OHAMR - EUP OHAMR and the first call launched in November 2025.
Contact
Partnership contact: secretariat@ohamr.eu
Commission services: RTD-COMBATTING-DISEASES@ec.europa.eu
What are partnerships?
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
How to use partnerships?
- orientation Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
- networking Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
- ecosystem analysis Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
- steering the agenda Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Author
Do you have an additional question? Or spotted a mistake? Don't hesitate to contact me!
Sarah Stroobants
sarah.stroobants@fwo.be